Alberti, A.
, Pirrone, P., Elia, M., Waring, R.H., & Romano, C. (1999). Sulphation deficit in ‘low-functioning’ autistic children: A pilot study. Biological Psychiatry, 46, 420-424.
2.
Buynak, E.B.
, Weibel, R.E., Whitman, J.E., Stokes, J., & Hilleman, M.R. (1969). Combined live measles mumps rubella virus vaccines. Journal of the American Medical Association, 207, 2259-2262.
3.
Cade, R.
, Privette, M., Fregly, M., Rowland, N., Sun, Z., Zele, V., Wagemaker, H., & Edelstein, C. (2000). Autism and schizophrenia: Intestinal disorders. Nutritional Neuroscience, 3, 57-72.
4.
Comi, A.M.
, Zimmerman, A.W., Frye, V.H., Law, P.A., & Peeden, J.H. (1999). Familial clustering of autoimmune disorders and evaluation of medical risks in autism. Journal of Child Neurology, 14, 388-394.
5.
Deykin, E.Y.
, & MacMahon, B. (1979). Viral exposure and autism. American Journal of Epidemiology, 109, 628-638.
6.
Furlano, R.
, Anthony, A., Day, R., et al. (2001). Quantitative immunohistochemistry shows colonic epithelial pathology and T cell infiltration in autistic enterocolitis. Journal of Pediatrics, 138, 366-372.
7.
Gupta, S.
, Aggarwal, S., Rashanravan, B., & Lee, T. (1998). Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. Journal of Neuroimmunology, 85, 106-109.
8.
Horvath, K.
, Papdimitriou, J.C., Rabsztyn, A., Drachenberg, C., & Tildon, J.T. (1999). Gastrointestinal abnormalities in children with autistic disorder. Journal of Paediatrics, 135, 559-563.
9.
Horvath, K.
, Zielke, R.H., Collins, R.M., Rabsztyn, A., Mederios, L.A., & Perman, J. (2000). Secretin improves intestinal permeability in autistic children. Journal of Paediatric Gastroenterology and Nutrition, 31 (Suppl. 2), A112.
10.
Jyonouchi, H.
, Sun, S., & Le, H. (2001). Proinflammatory and regulatory cytokines associated with innate and adaptive immune responses in children with autistic spectrum disorders and developmental regression. Journal of Neuroimmunology, 120, 170-179.
11.
Knivsberg, A.-M.
, Reichelt, K.-L., Nodland, M., & Hoien, T. (1995). Autistic syndromes and diet: A follow-up study. Scandinavian Journal of Educational Research, 39, 223-236.
12.
Ludviksson, B.R.
, Elriksson, T.H., Ardal, B., Sigfusson, A., & Valdimarsson, H. (1992). Correlation between serum immunoglobulin A concentrations and allergic manifestations in infants. Journal of Pediatrics, 121, 23-27.
13.
Minekawa, Y.
, Ueda, S., Yamanishi, K., Ogino, T., Takahashi, M., & Okuno, Y. (1974). Studies on live rubella vaccine V. Quantitative aspects of interference between rubella, measles and mumps viruses in their trivalent vaccine. Biken Journal, 17, 161-167.
Murch, S.H.
, Anthony, A., Thompson, M., et al. (1999). Ileo-colonic lymphoid nodular hyperplasia is associated with immunodeficiency in children with developmental disorders. Gut, 44, A127.
16.
Reichelt, K.-L.
, Ekrem, J., & Scott, H. (1990). Gluten, milk proteins and autism: Dietary intervention effects on behavior and peptide secretion. Journal of Applied Nutrition, 42, 1-11.
17.
Reichelt, K.-L.
, Knivsberg, A.-M., Nodland, M., & Lind, G. (1994). Nature and consequences of hyperpeptiduria and bovine casomorphins found in autistic syndromes. Developmental Brain Dysfunction, 7, 71-85.
18.
Rutter, M.
, Taylor, E., & Hersor, L. (1994). Child and adolescent psychiatry. London: Blackwell Scientific.
19.
Sandler, R.H.
, Finegold, S.M., Bolte, E.R., et al. (2000). Short-term benefit from oral vancomycin treatment of regressive-onset autism. Journal of Child Neurology, 15, 429-435.
20.
Singh, V.K.
, Lin, S.X., & Yang, V.C. (1998). Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism. Clinical Immunology and Immunopathology, 89, 105-108.
21.
Spitzer, W.O.
, Aitken, K.J., Dell’Aniello, S., & Davis, M.W.L. (2001). The natural history of autistic syndrome in British children unexposed to MMR. Adverse Drug Reactions and Toxocological Reviews, 20, 1-4.
22.
Stratton, K.
, Gable, A., Shetty, P., & McCormick, M. (2001). Immunization safety review: Measles-mumps-rubella vaccine and autism. Washington, DC: National Academy Press. Available: www.iom.edu/imsafety
23.
Sun, Z.
, & Cade, J.R. (1999). A peptide found in schizophrenia and autism causes behavioral changes in rats. Autism, 3, 85-95.
24.
Torrente, F.
, Machado, N., Perez-Machado, M., et al. (2000). Enteropathy with T cell infiltration and epithelial IgG deposition in autism. Journal of Paediatric Gastroenterology and Nutrition, 31 (Suppl. 2), A546.
25.
Uhlmann, V.
, Martin, C., Shiels, O., Wakefield, A.J., & O’Leary, J.J. (2002). Possible viral pathogenesis of a novel paediatric inflammatory bowel disease. Molecular Pathology (in press).
26.
Wakefield, A.J.
, Anthony, A., Murch, S.H., et al. (2000). Enterocolitis in children with developmental disorders. American Journal of Gastroenterology, 95, 2285-2295.
27.
Wakefield, A.J.
, Murch, S.H., Anthony, A., et al. (1998). Ileal-lymphoid nodular hyperplasian non-specific colitis, and pervasive developmental disorder in children. Lancet, 351, 637-641.
28.
Wakefield, A.J.
, Puleston, J., Montgomery, S.M., Anthony, A., O’Leary, J.J., & Murch, S.H. (2002) Entero-colonic encephalopathy, autism and opioid receptor ligands. Alimentary Pharmacology and Therapy, (in press).
29.
Warren, R.P.
, Singh, V.K., Averett, R.E., et al. (1996). Immunogenetic studies in autism and related disorders. Molecular and Clinical Neuropathology, 28, 77-81.
30.
Weibel, R.E.
, Caserta, V., & Benor, D.E. (1998). Acute encephalopathy followed by permanent brain injury or death associated with further attenuated measles vaccines: A review of claims submitted to the national vaccine injury compensation program. Paediatrics, 101, 383-387.
31.
Yazbak, F.E.
, & Lang-Radosh, K. (2001). Adverse outcomes associated with postpartum rubella or MMR vaccine. Medical Sentinel, 6, 95-99.
32.
Zinkernagel, R.M.
(2001). Maternal antibodies, childhood infections and autoimmune disease. New England Journal of Medicine, 345, 1331-1335.
